Trent M. Woodruff
TitleCited byYear
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
TM Woodruff, J Thundyil, SC Tang, CG Sobey, SM Taylor, TV Arumugam
Molecular neurodegeneration 6 (1), 11, 2011
3652011
Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment
KD Beck, HX Nguyen, MD Galvan, DL Salazar, TM Woodruff, ...
Brain 133 (2), 433-447, 2010
3592010
The role of the complement system in ischemia-reperfusion injury
TV Arumugam, IA Shiels, TM Woodruff, DN Granger, SM Taylor
shock 21 (5), 401-409, 2004
3522004
Toll-like receptors in ischemia-reperfusion injury
TV Arumugam, E Okun, SC Tang, J Thundyil, SM Taylor, TM Woodruff
Shock 32 (1), 4-16, 2009
3082009
Inhibiting the C5–C5a receptor axis
TM Woodruff, KS Nandakumar, F Tedesco
Molecular immunology 48 (14), 1631-1642, 2011
2272011
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
1682017
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer’s disease
MI Fonseca, RR Ager, SH Chu, O Yazan, SD Sanderson, FM LaFerla, ...
The Journal of Immunology 183 (2), 1375-1383, 2009
1652009
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ...
Science 352 (6292), aad1210, 2016
1602016
C5L2: a controversial receptor of complement anaphylatoxin, C5a
R Li, LG Coulthard, MCL Wu, SM Taylor, TM Woodruff
The FASEB Journal 27 (3), 855-864, 2013
1432013
Complement component 5a (C5a)
HD Manthey, TM Woodruff, SM Taylor, PN Monk
The international journal of biochemistry & cell biology 41 (11), 2114-2117, 2009
1402009
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease
TM Woodruff, TV Arumugam, IA Shiels, RC Reid, DP Fairlie, SM Taylor
The Journal of Immunology 171 (10), 5514-5520, 2003
1372003
A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats
AJ Strachan, TM Woodruff, G Haaima, DP Fairlie, SM Taylor
The Journal of Immunology 164 (12), 6560-6565, 2000
1372000
Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
TV Arumugam, TM Woodruff, JD Lathia, PK Selvaraj, MP Mattson, ...
Neuroscience 158 (3), 1074-1089, 2009
1352009
Complement mediators in ischemia–reperfusion injury
TV Arumugam, T Magnus, TM Woodruff, LM Proctor, IA Shiels, SM Taylor
Clinica Chimica Acta 374 (1-2), 33-45, 2006
1352006
Antiarthritic activity of an orally active C5a receptor antagonist against antigen‐induced monarticular arthritis in the rat
TM Woodruff, AJ Strachan, N Dryburgh, IA Shiels, RC Reid, DP Fairlie, ...
Arthritis & Rheumatism 46 (9), 2476-2485, 2002
1292002
Dendritic cell function in allostimulation is modulated by C5aR signaling
Q Peng, K Li, N Wang, Q Li, E Asgari, B Lu, TM Woodruff, SH Sacks, ...
The Journal of Immunology 183 (10), 6058-6068, 2009
1212009
Protective effect of a new C5a receptor antagonist against ischemia–reperfusion injury in the rat small intestine
TV Arumugam, IA Shiels, TM Woodruff, RC Reid, DP Fairlie, SM Taylor
Journal of Surgical Research 103 (2), 260-267, 2002
1192002
The role of the complement system and the activation fragment C5a in the central nervous system
TM Woodruff, RR Ager, AJ Tenner, PG Noakes, SM Taylor
Neuromolecular medicine 12 (2), 179-192, 2010
1162010
Neutrophils—a key component of ischemia-reperfusion injury
ZV Schofield, TM Woodruff, R Halai, MCL Wu, MA Cooper
Shock 40 (6), 463-470, 2013
1142013
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
TM Woodruff, JW Crane, LM Proctor, KM Buller, AB Shek, K De Vos, ...
The FASEB Journal 20 (9), 1407-1417, 2006
1092006
The system can't perform the operation now. Try again later.
Articles 1–20